In this second part of episode 4, RV Radio with Robinson Ventures continue the conversation with four members of the ThinkGenetic Leadership Team to focus the conversation on the day-to-day… CONTINUE
ThinkGenetic Announces Rene Matz as New Vice President of Business Development to Expand Global Adoption of Genetic Condition Product Lines FindEHR and SymptomMatcher
ThinkGenetic, Inc. recently announced the hire of business development expert, Rene Matz, RN as Vice President of Business Development. She will be primarily responsible for collaborating with pharmaceutical, biotech companies,… CONTINUE
Ochsner Lafayette Healthcare Innovation Fund Invests in ThinkGenetic Vision for Genetic Disease Identification in Local Patients
LAFAYETTE, La., April 20, 2021 (Newswire.com) – Today ThinkGenetic, Inc. (thinkgenetic.com) announces the official acceptance of a $500,000 investment from the Ochsner Lafayette General Healthcare Innovation Fund. “After years of working… CONTINUE
MetroWest Daily News: Sudbury startup aids in diagnosing genetic conditions
Original article: https://www.metrowestdailynews.com/news/20190307/sudbury-startup-aids-in-diagnosing-genetic-conditions By Zane Razzaq Daily News staff SUDBURY – With the average patient struggling to find a diagnosis for a genetic condition for several years, a Sudbury family is… CONTINUE
ThinkGenetic Partners with Genome Medical
New Partnership Strengthens ThinkGenetic’s Continued Effort to Reduce Time to Diagnosis In an influential move for the genetics community, ThinkGenetic (ThinkGenetic.com) and Genome Medical (GenomeMedical.com), a nationwide specialty medical practice… CONTINUE
2017 – ThinkGenetic Builds Patient – First Reputation with SymptomMatcher and More
As the President of ThinkGenetic, I am responsible for ensuring the company makes steady progress toward our goals. I provide regular feedback on this progress to our board members, investors,… CONTINUE
Stealth BioTherapeutics Supports Addition of Mitochondrial Genetic Diseases in ThinkGenetic Knowledge Base
In a public press release this week, ThinkGenetic announced that Stealth BioTherapeutics (Stealth) has funded content design, content creation, and clinical trials advertising for mitochondrial diseases. As a first step… CONTINUE
Fabry Disease Study Using ThinkGenetic Diagnostic Aid to be Showcased at WORLDSymposium
ThinkGenetic SymptomMatcherTM Diagnostic Aid Tested for Patients with Fabry Disease in Study by Emory University School of Medicine, Grady Memorial Hospital and University of Georgia College of Pharmacy ThinkGenetic today… CONTINUE
Connecting, Collaborating, and Activating at the Vibrant 2017 RARE Patient Advocacy Summit
While many of our ThinkGenetic teammates helped others “harness their inner power” at the National Society of Genetic Counselors Annual Conference in Columbus, Ohio, ThinkGenetic CEO, Dave Jacob and I… CONTINUE
Harnessing the Power Within at the 2017 National Society of Genetic Counselors Annual Conference
Have you ever been able to achieve something you never thought possible, yet when you look back you realize that you always had the power to do it? Maybe someone… CONTINUE